These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16616288)

  • 1. Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complex.
    Herrera C; Klasse PJ; Kibler CW; Michael E; Moore JP; Beddows S
    Virology; 2006 Jul; 351(1):121-32. PubMed ID: 16616288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41.
    Salzwedel K; Berger EA
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12794-9. PubMed ID: 11050186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1.
    Iwatani Y; Kawano K; Ueno T; Tanaka M; Ishimoto A; Ito M; Sakai H
    Virology; 2001 Jul; 286(1):45-53. PubMed ID: 11448157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120.
    Day JR; Van Damme N; Guatelli JC
    Virology; 2006 Oct; 354(2):316-27. PubMed ID: 16905171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
    Alsahafi N; Debbeche O; Sodroski J; Finzi A
    PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity.
    Chen SS; Ferrante AA; Terwilliger EF
    Virology; 1996 Dec; 226(2):260-8. PubMed ID: 8955046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
    Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles.
    Herrera C; Klasse PJ; Michael E; Kake S; Barnes K; Kibler CW; Campbell-Gardener L; Si Z; Sodroski J; Moore JP; Beddows S
    Virology; 2005 Jul; 338(1):154-72. PubMed ID: 15932765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant HIV envelope expressed in an alpha-glucosidase I-deficient CHO cell line and its parental cell line in the presence of 1-deoxynojirimycin is functional.
    Fenouillet E; Papandréou MJ; Jones IM
    Virology; 1997 Apr; 231(1):89-95. PubMed ID: 9143306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected.
    Crooks ET; Tong T; Osawa K; Binley JM
    J Virol; 2011 Jun; 85(12):5825-39. PubMed ID: 21471242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage.
    Pancera M; Wyatt R
    Virology; 2005 Feb; 332(1):145-56. PubMed ID: 15661147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120.
    Hoorelbeke B; van Montfort T; Xue J; LiWang PJ; Tanaka H; Igarashi Y; Van Damme EJ; Sanders RW; Balzarini J
    FEBS Lett; 2013 Apr; 587(7):860-6. PubMed ID: 23454641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein.
    Nguyen HT; Madani N; Ding H; Elder E; Princiotto A; Gu C; Darby P; Alin J; Herschhorn A; Kappes JC; Mao Y; Sodroski JG
    Virol J; 2017 Feb; 14(1):33. PubMed ID: 28209172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
    Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
    Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dominant-negative action of a fusion protein containing the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 in virus replication.
    Chan WE; Chen SS
    J Biomed Sci; 2007 Nov; 14(6):717-29. PubMed ID: 17610148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of signal peptide exchange on HIV-1 glycoprotein expression and viral infectivity in mammalian cells.
    Pfeiffer T; Pisch T; Devitt G; Holtkotte D; Bosch V
    FEBS Lett; 2006 Jun; 580(15):3775-8. PubMed ID: 16777098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1.
    Merat R; Raoul H; Leste-Lasserre T; Sonigo P; Pancino G
    J Virol; 1999 Jul; 73(7):5698-706. PubMed ID: 10364320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the coevolutionary patterns operating within the env gene of the HIV-1 group M subtypes.
    Travers SA; Tully DC; McCormack GP; Fares MA
    Mol Biol Evol; 2007 Dec; 24(12):2787-801. PubMed ID: 17921487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses.
    Blay WM; Kasprzyk T; Misher L; Richardson BA; Haigwood NL
    J Virol; 2007 Dec; 81(23):13037-49. PubMed ID: 17855534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.